Journal of Neuroinflammation is a premier open-access journal published by BMC that has been at the forefront of research in the field since its inception in 2004. With a strong focus on the intricate interplay between the nervous system and immune responses, this journal aims to create a forum for the dissemination of high-quality research that informs our understanding of neuroinflammation and its implications in neurological disorders. Positioned in the top quartile across multiple categories including Cellular and Molecular Neuroscience, Immunology, and Neurology, the journal ranks impressively within the Scopus database, ensuring visibility to the global research community. The Journal of Neuroinflammation provides a vital platform for researchers and professionals to share groundbreaking findings, methodologies, and reviews that advance science and foster collaboration. With its commitment to open access, the journal ensures that its content is accessible to a broad audience, enhancing the dissemination of knowledge in this critical field of study.

JOURNAL OF NEUROIMMUNOLOGY is a premier academic journal dedicated to exploring the intricate interactions between the nervous and immune systems. Published by Elsevier, this journal has been at the forefront of neuroimmunology research since its inception in 1981 and continues to disseminate high-quality, peer-reviewed articles that are critical for advancing understanding in the fields of immunology, neurology, and neuroscience. With an impressive impact factor and a Q2 ranking in multiple categories including Neurology and Immunology and Allergy, it serves as an essential resource for researchers, clinicians, and students alike who seek to deepen their knowledge of the neuroimmune landscape. The journal’s rigorous selection process ensures that only the most relevant and impactful research is published, fostering a vibrant academic discourse and facilitating knowledge transfer among professionals in the field. Although the journal is not open access, its contributions to both therapeutic insights and foundational research make it a valuable asset for those committed to the advancement of neuroimmunological science.

EXERCISE IMMUNOLOGY REVIEW, published by W W F VERLAGSGESELLSCHAFT GMBH, stands as a premier journal within the realms of Immunology, Medicine, and Sports Science. With an impressive Q1 ranking in these fields as of 2023, it is recognized for its significant contributions to understanding the interplay between physical activity and immune function. The journal, which has been publishing since 1996 and continues to evolve through 2024, serves as an essential resource for researchers, professionals, and students eager to explore cutting-edge findings and discussions. Although it is not an open access publication, its content is accessible through institutional subscriptions and individual purchases, ensuring its reach across a global audience. As the journal consistently ranks in the 96th percentile in General Medicine on Scopus, it underscores its vital role in advancing the dialogue on how exercise influences health and disease management.

EXPERIMENTAL NEUROLOGY is a premier academic journal published by Academic Press Inc, Elsevier Science, focusing on advancements in the fields of Developmental Neuroscience and Neurology. With an impressive Impact Factor and ranked in the Q1 quartile of both categories—positioning it among the top-tier journals—this publication has established itself as a vital resource for researchers, clinicians, and students alike. Since its inception in 1959, it has fostered the dissemination of cutting-edge research and innovative approaches to understanding neurological function and related disorders. While EXPERIMENTAL NEUROLOGY currently operates under a subscription access model, its rich archives and ongoing contributions to the field continue to inspire and inform the next generation of neurobiologists. The journal also boasts a high ranking in Scopus, placing fourth in Developmental Neuroscience and twentieth in Neurology, indicating its robust influence and scholarly significance. For those committed to advancing knowledge in these critical areas, EXPERIMENTAL NEUROLOGY is an indispensable platform for inquiry and discovery.

NEUROENDOCRINOLOGY LETTERS is a distinguished academic journal published by MAGHIRA & MAAS PUBLICATIONS, focusing on the intricate interplay between the nervous system and the endocrine system. Since its inception in 1979, the journal has provided a vital platform for researchers and practitioners in the fields of endocrinology, psychiatry, and neurology, making significant contributions to our understanding of neuroendocrine mechanisms and their clinical implications. Although currently categorized in the Q4 quartile across several disciplines, including Endocrine and Autonomic Systems and Neurology, the journal continues to strive for excellence in disseminating quality research. With an ISSN of 0172-780X and E-ISSN 2354-4716, it allows for global engagement, albeit not currently available as Open Access. The journal's impact on its respective fields is underscored by its steady publication trajectory from its initial years to 2024, making it an essential resource for students, professionals, and researchers seeking to explore the dynamic relationships within neuroendocrinology.

Immunity, Inflammation and Disease is a premier open-access journal published by WILEY, dedicated to advancing the field of immunology and allergy. Launched in 2013, this journal has established itself as a significant platform for researchers and professionals to disseminate high-quality research findings and innovative insights that address critical issues in immune responses and inflammatory diseases. With an impact factor that reflects its growing influence and a current ranking in Q3 for Immunology and Q2 for Immunology and Allergy, this journal serves a diverse audience keen on exploring cutting-edge developments. Researchers are encouraged to submit their work to share their findings with a global reach, foster collaboration, and enhance the understanding of immune mechanisms and therapeutic strategies. Accessible since its inception, Immunity, Inflammation and Disease is committed to open science, ensuring that vital research is freely available for the advancement of knowledge within the academic community and beyond.

NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY is a prominent journal dedicated to advancing the field of clinical neurophysiology, published by Elsevier France - Éditions Scientifiques Médicales Elsevier. With an ISSN of 0987-7053 and an E-ISSN of 1769-7131, this journal serves as a vital platform for disseminating high-quality research and insights from 1988 through 2024. As evidenced by its excellence, the journal currently holds a Q2 ranking in the categories of Medicine (miscellaneous), Neurology, Clinical Neurology, and Medical Physiology, reflecting its impact and relevance in these critical fields. Additionally, the Scopus rankings underscore its contribution to the scientific community, particularly in clinical neurology and physiology. Researchers, professionals, and students in neurophysiology will find this journal crucial for accessing innovative studies and enhancing their understanding of clinical practices. While access to articles may vary, the journal's commitment to excellence continues to engage an international readership, fostering collaboration and knowledge advancement in the neurophysiology domain.

Pain Reports, published by LIPPINCOTT WILLIAMS & WILKINS, is a premier open access journal dedicated to advancing the field of anesthesiology and pain medicine. With an impressive impact factor and a ranking of #15 out of 136 in its category, this journal is recognized within the 89th percentile of its field as of 2023. Since its launch in 2016, Pain Reports has provided a vital platform for researchers, clinicians, and professionals to disseminate and access high-quality research articles, reviews, and case studies focused on the multifaceted aspects of pain management and treatment. Through its commitment to open access, the journal ensures that cutting-edge findings are readily available to a global audience, facilitating collaboration and knowledge sharing. With its scope continually evolving until 2024, Pain Reports strives to address the critical and emerging challenges in pain research, making it an essential resource for individuals dedicated to improving patient outcomes and advancing scholarly discourse in pain management.

NEUROMOLECULAR MEDICINE, published by HUMANA PRESS INC, is a prestigious peer-reviewed journal dedicated to advancing the fields of cellular and molecular neuroscience, molecular medicine, and neurology. With an ISSN of 1535-1084 and an E-ISSN of 1559-1174, the journal boasts a significant presence in academic research since its inception in 2002 and continues to publish cutting-edge studies through 2024. Ranked in the Q2 category for 2023 in various disciplines, including Neuroscience and Molecular Medicine, it holds impressive positions in Scopus rankings, including 41st out of 192 in Neuroscience and Neurology. Although not an open access journal, NEUROMOLECULAR MEDICINE remains invaluable for researchers, professionals, and students seeking to explore the intricate relationships between molecular mechanisms and neurological functions, thereby contributing to the scientific understanding of nervous system diseases and therapeutic innovations.

BMC NEUROSCIENCE is a prominent open access journal dedicated to the dissemination of high-quality research within the dynamic and rapidly evolving field of neuroscience. Published by BMC, a well-respected leader in open access publishing, this journal facilitates the free exchange of knowledge since its inception in 2000. With the ISSN 1471-2202, BMC NEUROSCIENCE aims to address the diverse interests of the neuroscience community by covering a broad spectrum of topics, ranging from cellular and molecular neuroscience to general neurological studies, thus appealing to researchers, professionals, and students alike. Although it currently holds a Q4 ranking in Cellular and Molecular Neuroscience and a Q3 rank in miscellaneous Neuroscience categories, its commitment to advancing the understanding of brain function and disorders remains steadfast. The journal features a user-friendly Open Access model, ensuring that critical research findings are readily accessible to everyone, fostering collaboration and innovation in the field. As the journal continues to evolve towards its convergence years of 2024, it aspires to enhance its impact and global reach, making it a valuable resource for anyone interested in advancing neuroscience research.